August 21, 2017 / 8:14 PM / a year ago

Appeals court revives Lipitor, Effexor pay-for-delay cases

A federal appeals court on Monday revived antitrust lawsuits against Pfizer Inc and other companies, claiming they entered into deals that unlawfully delayed the availability of generic versions of Lipitor and Effexor XR.

The 3rd U.S. Circuit Court of Appeals in Philadelphia ruled the lawsuits plausibly alleged Pfizer and Wyeth, which it later acquired, entered into unlawful reverse payment settlement agreements with generic drugmakers they sued for patent infringement.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below